GATA2 is required for lymphatic vessel valve development and maintenance

Journal of Clinical Investigation

Volumn 125, Issue 8, 2015, Pages 2879-2994

  Kazenwadel, Jan ^a   Betterman, Kelly L ^a   Chong, Chan Eng ^a   Stokes, Philippa H ^b   Lee, Young K ^a   Secker, Genevieve A ^a   Agalarov, Yan ^c   Demir, Cansaran Saygili ^c   Lawrence, David M ^a,d   Sutton, Drew L ^a   Tabruyn, Sebastien P ^a   Miura, Naoyuki ^e   Salminen, Marjo ^f   Petrova, Tatiana V ^c,g   Matthews, Jacqueline M ^b   Hahn, Christopher N ^a,h   Scott, Hamish S ^a,d,h   Harvey, Natasha L ^a,h  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF HELSINKI   (Finland)

^g EPFL   (Switzerland)

^h UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; PROTEIN PROX1; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR NFATC1; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; GATA2 PROTEIN, HUMAN; GATA2 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; NFATC1 PROTEIN, HUMAN; NFATC1 PROTEIN, MOUSE; PROSPERO-RELATED HOMEOBOX 1 PROTEIN; TRANSCRIPTION FACTOR NFAT; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; BINDING AFFINITY; CAPILLARY ENDOTHELIAL CELL; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; ENHANCER REGION; GENE DELETION; GENE LOCUS; GENETIC TRANSCRIPTION; GERMLINE MUTATION; HAPLOINSUFFICIENCY; HEART VALVE; HEMATOPOIESIS; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; LYMPHANGIOGENESIS; LYMPHEDEMA; MISSENSE MUTATION; MOUSE; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; REPORTER GENE; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; ANIMAL; EMBRYOLOGY; GENETICS; K562 CELL LINE; LYMPH VESSEL; METABOLISM; MUTATION; PATHOLOGY;

ANIMALS; ENHANCER ELEMENTS, GENETIC; FORKHEAD TRANSCRIPTION FACTORS; GATA2 TRANSCRIPTION FACTOR; GENE DELETION; HOMEODOMAIN PROTEINS; HUMANS; K562 CELLS; LYMPHATIC VESSELS; LYMPHEDEMA; MICE; MUTATION; NFATC TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84939243994     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI78888     Document Type: Article

References (68)

1. Mansour S, et al. Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases. Am J Med Genet A. 2010;152A(9):2287-2296.
2. Ostergaard P, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011;43(10):929-931.
3. Kazenwadel J, et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood. 2012;119(5):1283-1291.
4. Ishida H, et al. GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia. Eur J Pediatr. 2012;171(8):1273-1276.
5. Khandekar M, et al. A Gata2 intronic enhancer confers its pan-endothelia-specific regulation. Development. 2007;134(9):1703-1712.
6. Mammoto A, et al. A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature. 2009;457(7233):1103-1108.
7. Pimanda JE, et al. Endoglin expression in blood and endothelium is differentially regulated by modular assembly of the Ets/Gata hemangioblast code. Blood. 2008;112(12):4512-4522.
8. Linnemann AK, O'Geen H, Keles S, Farnham PJ, Bresnick EH. Genetic framework for GATA factor function in vascular biology. Proc Natl Acad Sci U S A. 2011;108(33):13641-13646.
9. Muiya NP, et al. A study of the role of GATA2 gene polymorphism in coronary artery disease risk traits. Gene. 2014;544(2):152-158.
10. Connelly JJ, et al. GATA2 is associated with familial early-onset coronary artery disease. PLoS Genet. 2006;2(8):e139.
11. Liu YH, et al. Gene polymorphisms associated with susceptibility to coronary artery disease in Han Chinese people. Genet Mol Res. 2014;13(2):2619-2627.
12. Zhu C, et al. Evaluation and application of modularly assembled zinc-finger nucleases in zebrafish. Development. 2011;138(20):4555-4564.
13. Lim KC, et al. Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning. J Clin Invest. 2012;122(10):3705-3717.
14. Johnson KD, et al. Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. J Clin Invest. 2012;122(10):3692-3704.
15. Petrova TV, et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med. 2004;10(9):974-981.
16. Sabine A, Petrova TV. Interplay of mechanotransduction, FOXC2, connexins, and calcineurin signaling in lymphatic valve formation. Adv Anat Embryol Cell Biol. 2014;214:67-80.
17. Bazigou E, Makinen T. Flow control in our vessels: vascular valves make sure there is no way back. Cell Mol Life Sci. 2012;70(6):1055-1066.
18. Koltowska K, Betterman KL, Harvey NL, Hogan BM. Getting out and about: the emergence and morphogenesis of the vertebrate lymphatic vasculature. Development. 2013;140(9):1857-1870.
19. Bazigou E, et al. Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell. 2009;17(2):175-186.
20. Sabine A, et al. Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation. Dev Cell. 2012;22(2):430-445.
21. Danussi C, et al. EMILIN1/alpha9beta1 integrin interaction is crucial in lymphatic valve formation and maintenance. Mol Cell Biol. 2013;33(22):4381-4394.
22. Norrmen C, et al. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol. 2009;185(3):439-457.
23. Makinen T, et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 2005;19(3):397-410.
24. Kanki Y, et al. Epigenetically coordinated GATA2 binding is necessary for endothelium-specific endomucin expression. EMBO J. 2011;30(13):2582-2595.
25. Murtomaki A, et al. Notch signaling functions in lymphatic valve formation. Development. 2014;141(12):2446-2451.
26. Jurisic G, et al. An unexpected role of semaphorin3a-neuropilin-1 signaling in lymphatic vessel maturation and valve formation. Circ Res. 2012;111(4):426-436.
27. Bouvree K, et al. Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. Circ Res. 2012;111(4):437-445.
28. Gale NW, et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell. 2002;3(3):411-423.
29. Dellinger M, et al. Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. Dev Biol. 2008;319(2):309-320.
30. Shen B, et al. Genetic dissection of tie pathway in mouse lymphatic maturation and valve development. Arterioscler Thromb Vasc Biol. 2014;34(6):1221-1230.
31. Levet S, et al. Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation. Blood. 2013;122(4):598-607.
32. Bazigou E, et al. Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J Clin Invest. 2011;121(8):2984-2992.
33. Srinivasan RS, Oliver G. Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves. Genes Dev. 2011;25(20):2187-2197.
34. van der Putte SC. The early development of the lymphatic system in mouse embryos. Acta Morphol Neerl Scand. 1975;13(4):245-286.
35. Hess PR, et al. Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life. J Clin Invest. 2014;124(1):273-284.
36. Turner CJ, Badu-Nkansah K, Crowley D, van der Flier A, Hynes RO. Integrin-α5β1 is not required for mural cell functions during development of blood vessels but is required for lymphatic-blood vessel separation lymphovenous valve formation. Dev Biol. 2014;392(2):381-392.
37. Bresnick EH, Katsumura KR, Lee HY, Johnson KD, Perkins AS. Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies. Nucleic Acids Res. 2012;40(13):5819-5831.
38. Charles MA, et al. Pituitary-specific Gata2 knockout: effects on gonadotrope and thyrotrope function. Mol Endocrinol. 2006;20(6):1366-1377.
39. Kala K, et al. Gata2 is a tissue-specific postmitotic selector gene for midbrain GABAergic neurons. Development. 2009;136(2):253-262.
40. Zhou Y, et al. Rescue of the embryonic lethal hematopoietic defect reveals a critical role for GATA-2 in urogenital development. EMBO J. 1998;17(22):6689-6700.
41. Tsai FY, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 1994;371(6494):221-226.
42. Rodrigues NP, et al. Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood. 2005;106(2):477-484.
43. de Pater E, et al. Gata2 is required for HSC generation and survival. J Exp Med. 2013;210(13):2843-2850.
44. Wilson NK, et al. Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell. 2010;7(4):532-544.
45. Tijssen MR, et al. Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators. Dev Cell. 2011;20(5):597-609.
46. Fujiwara T, et al. Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol Cell. 2009;36(4):667-681.
47. Martin DI, Orkin SH. Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1. Genes Dev. 1990;4(11):1886-1898.
48. Omichinski JG, et al. NMR structure of a specific DNA complex of Zn-containing DNA binding domain of GATA-1. Science. 1993;261(5120):438-446.
49. Spinner MA, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2013;123(6):809-821.
50. Francois M, et al. Sox18 induces development of the lymphatic vasculature in mice. Nature. 2008;456(7222):643-647.
51. Hahn CN, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43(10):1012-1017.
52. Chen Y, et al. DNA binding by GATA transcription factor suggests mechanisms of DNA looping and long-range gene regulation. Cell Rep. 2012;2(5):1197-1206.
53. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell. 1999;98(6):769-778.
54. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol. 2001;230(2):230-242.
55. Haugas M, Lillevali K, Hakanen J, Salminen M. Gata2 is required for the development of inner ear semicircular ducts and the surrounding perilymphatic space. Dev Dyn. 2010;239(9):2452-2469.
56. Srinivasan RS, et al. Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev. 2007;21(19):2422-2432.
57. Grass JA, et al. Distinct functions of dispersed GATA factor complexes at an endogenous gene locus. Mol Cell Biol. 2006;26(19):7056-7067.
58. Huang Z, et al. GATA-2 reinforces megakaryocyte development in the absence of GATA-1. Mol Cell Biol. 2009;29(18):5168-5180.
59. Heintzman ND, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet. 2007;39(3):311-318.
60. Cao R, et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science. 2002;298(5595):1039-1043.
61. Robert-Moreno A, Espinosa L, de la Pompa JL, Bigas A. RBPjkappa-dependent Notch function regulates Gata2 and is essential for the formation of intra-embryonic hematopoietic cells. Development. 2005;132(5):1117-1126.
62. Guiu J, et al. Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling. J Exp Med. 2013;210(1):71-84.
63. Oren T, Torregroza I, Evans T. An Oct-1 binding site mediates activation of the gata2 promoter by BMP signaling. Nucleic Acids Res. 2005;33(13):4357-4367.
64. Tsuzuki S, Kitajima K, Nakano T, Glasow A, Zelent A, Enver T. Cross talk between retinoic acid signaling and transcription factor GATA-2. Mol Cell Biol. 2004;24(15):6824-6836.
65. Bowles J, et al. Control of retinoid levels by CYP26B1 is important for lymphatic vascular development in the mouse embryo. Dev Biol. 2013;386(1):25-33.
66. Rivera-Feliciano J, et al. Development of heart valves requires Gata4 expression in endothelial-derived cells. Development. 2006;133(18):3607-3618.
67. Garg V, et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature. 2003;424(6947):443-447.
68. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet. 1999;21(1):70-71.